This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on may 2, 2019.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added exp date).G4 (date received by manufacturer).G7 (indication that this is a follow-up report).H2 (follow-up due to additional information and device evaluation).H3 (device evaluated by manufacturer).H4 (device manufacture date).H6 (identification of evaluation codes (10, 11, 3331, 3259, 19).Method code #1: 10 - testing of actual/suspected device.Method code #2: 11 - testing of device from same lot/batch retained by manufacturer.Method code #3: 3331- analysis of production records.Results code: 3259 - improper physical structure.Conclusions code: 19 - cause traced to user.Visual inspection of the returned sample confirmed that the reservoir lid was cracked.There was also damage to one of the luer ports on the lid.A representative retention sample from the same lot number was obtained and visually inspected; it was confirmed that all ports and the reservoir lid were intact and no anomalies noted related to the damage on the ports and reservoir lid or anywhere on the device.All capiox units are 100% visually inspected at several points in the production process.It is likely that the observed damage was caused by a shock force due to mishandling after unboxing.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|